[Corrigendum] Rab22a is a novel prognostic marker for cell progression in breast cancer.
Int J Mol Med
; 47(3)2021 03.
Article
in En
| MEDLINE
| ID: mdl-33655335
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Int J Mol Med
Year:
2021
Document type:
Article